Show simple item record

dc.contributor.authorSkubisz, Monika M.
dc.contributor.authorTong, Stephen
dc.contributor.authorDoust, Ann
dc.contributor.authorMollison, Jill
dc.contributor.authorJohns, Terrance G.
dc.contributor.authorNeil, Peter
dc.contributor.authorRobinson, Miranda
dc.contributor.authorBhattacharya, Siladitya
dc.contributor.authorWallace, Euan
dc.contributor.authorKrzys, Nicole
dc.contributor.authorColin Duncan, W.
dc.contributor.authorHorne, Andrew W.
dc.date.accessioned2018-07-30T09:33:08Z
dc.date.available2018-07-30T09:33:08Z
dc.date.issued2018-07
dc.identifier.citationSkubisz , M M , Tong , S , Doust , A , Mollison , J , Johns , T G , Neil , P , Robinson , M , Bhattacharya , S , Wallace , E , Krzys , N , Colin Duncan , W & Horne , A W 2018 , ' Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L : Phase II Open Label, Single Arm Multi-Centre Trial ' EBioMedicine , vol. 33 , pp. 276-281 . DOI: 10.1016/j.ebiom.2018.06.017en
dc.identifier.otherPURE: 130181847
dc.identifier.otherPURE UUID: 9ae71dd6-3a67-47ca-8893-4da701ba3065
dc.identifier.otherScopus: 85048938616
dc.identifier.urihttp://hdl.handle.net/2164/10826
dc.identifier.urihttp://www.scopus.com/inward/record.url?scp=85048938616&partnerID=8YFLogxKen
dc.descriptionThis work was supported by an NHMRC Grant (#1008276) to ST, TJ and EW, and an MRC Centenary Award (G0802808) to AH. The funders had no role study design, collection, analysis, and interpretation of data; in the writing of the report or in the decision to submit the paper.en
dc.format.extent6en
dc.language.isoeng
dc.relation.ispartofEBioMedicineen
dc.rights© 2018 Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)en
dc.subjectEctopic pregnancyen
dc.subjectGefitiniben
dc.subjectMedical treatmenten
dc.subjectMethotrexateen
dc.subjectPhase IIen
dc.subjectR Medicineen
dc.subjectBiochemistry, Genetics and Molecular Biology(all)en
dc.subjectMedical Research Council (MRC)en
dc.subjectG0802808en
dc.subject.lccRen
dc.titleGefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L : Phase II Open Label, Single Arm Multi-Centre Trialen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen, University of Aberdeenen
dc.contributor.institutionUniversity of Aberdeen, Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Data Safe Havenen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.ebiom.2018.06.017


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record